| 52-Week High | 219.57 |
|---|---|
| Last Price | 218.96 |
| Fibonacci 61.8% | 168.95 |
| Fibonacci 50% | 153.32 |
| Fibonacci 38.2% | 137.68 |
Should I invest in GW Pharmaceuticals?
The condition is typically diagnosed in childhood. The EMA approved GW's cannabidiol oral solution in September 2019 as adjunctive therapy for seizures associated with Lennox-Gastaut Syndrome or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.
Is gwph a good buy?
Why Investors Should Buy GW Pharmaceuticals Stock. GW's pathway to profitability is clear, making GW stock a good investment. By Will Ashworth, InvestorPlace Contributor Sep 16, 2019, 8:30 am EDT...
Should you buy gwph stock?
GW Pharma’s Epidiolex, the first marijuana-derived drug to be approved in the United States, generated sales of over $500 million for the U.K.-based company last year. Analysts expect sales to breach $1 billion soon.
Is GW Pharmaceuticals a buy?
There are currently 10 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GW Pharmaceuticals stock.
See more
What happened to GW Pharmaceuticals?
DUBLIN , May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
Is GWPH a good stock to buy?
GW Pharma has 0.47% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
What is the stock symbol for GW Pharmaceuticals?
GW Pharmaceuticals trades on the NASDAQ under the ticker symbol "GWPH."
Who is buying GW Pharmaceuticals?
Jazz PharmaceuticalsOn Friday, shareholders of GW Pharmaceuticals (GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (JAZZ 2.08%), both companies announced in a joint press release.
How do I buy GW Pharmaceutical stock?
How to buy shares in GW PharmaceuticalsCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is GW Pharmaceuticals public?
GW Leads the Pack Another top performing publicly traded cannabis company was GW Pharmaceuticals, which was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $225 per share earlier this year.
How much did jazz Buy GW for?
$7.2 billionJazz agreed to pony up $7.2 billion for cannabinoid hotshot GW Pharmaceuticals, whose epilepsy med Epidiolex could be on its way to blockbuster sales. The deal will move Jazz into the epilepsy market, expanding its current offerings beyond sleep disorders and cancer.
What company owns Epidiolex?
The FDA just approved Epidiolex, the GW Pharma seizure drug derived from cannabis, giving children with two rare and serious forms of epilepsy a new treatment—and companies looking to develop marijuana-based drugs a model for their own path to market.
Who owns Jazz Pharmaceuticals?
Bruce C. CozaddJazz PharmaceuticalsTypePublic companyKey peopleBruce C. Cozadd (Chairman & CEO)ProductsPharmaceutical drugsBrandsXyrem Erwinaze Defitelio FazaClo FazaClo HD Luvox CR Prialt VyxeosRevenueUS$1.618 billion (2017)13 more rows
Who did Jazz Pharma buy?
GW Pharmaceuticals plc(Reuters) - Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal which will bolster its neuroscience business with the addition of a cannabis-based epilepsy treatment.
What is the cost of Epidiolex?
Epidiolex rollout: $32,500 list price spurs critics as first cannabis drug hits shelves. It's official—the first FDA approved CBD product is on the market. GW Pharmaceuticals announced this morning that its cannabinoid Epidiolex, approved in the treatment of two rare forms of epilepsy, is now available by prescription.
Who founded Jazz Pharmaceuticals?
Bruce C CozaddChairman/CEO/Co-Founder, Jazz Pharmaceuticals PLC.
About GW Pharmaceuticals
GW Pharmaceuticals (NASDAQ:GWPH) Frequently Asked Questions
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas.
